Group 1 - Zhejiang Haisen Pharmaceutical Co., Ltd. announced the promotion of Wu Yangkuan to Vice General Manager, effective August 2025 [1] - Wu Yangkuan, aged 32, has been with the company since 2018, holding various positions before his current promotion [1] - His current salary is reported at 126,400 RMB, significantly lower than the average salary for Vice General Managers, which exceeds 600,000 RMB [2] Group 2 - As of August 15, the company's total market value is approximately 4.08 billion RMB, with a stock price increase of 63.87% over the past year [3] - For the fiscal year 2024, the company achieved a revenue of 472 million RMB, representing a year-on-year growth of 18.63%, and a net profit of 123 million RMB, up 17.09% [3] - In the first half of 2025, the company reported revenues of about 242 million RMB, a 14.93% increase, and a net profit of approximately 60.79 million RMB, growing by 4.74% [3] - The company is expanding its production capacity and enhancing its research and development capabilities with new projects underway [3]